NICOLE CLINCHARD: Open Payments
NPI 1902088149 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 33 payments from 10 companies in 2025. Trend: 2023 $476 · 2024 $1,353 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 1 | $145 |
| ABBVIE INC. | 9 | $139 |
| Janssen Biotech, Inc. | 6 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $112 |
| QOL Medical, LLC | 3 | $95 |
| Ardelyx, Inc. | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 3 | $39 |
| Lilly USA, LLC | 2 | $37 |
| Intercept Pharmaceuticals, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: TREMFYA, ENTYVIO, Sucraid, RINVOQ, IBSRELA, VOQUEZNA, OMVOH, SKYRIZI.
Industry payments across NC — which companies pay providers there.
